Bone marrow transplantation for Fanconi anemia. Adjustment of the dose of cyclophosphamide for preconditioning.

M Yabe, H Yabe, M Matsuda, T Hinohara, Y Oh, K Hattori, K Ishikawa, T Ohshima, H Yamamoto, S Kato
{"title":"Bone marrow transplantation for Fanconi anemia. Adjustment of the dose of cyclophosphamide for preconditioning.","authors":"M Yabe,&nbsp;H Yabe,&nbsp;M Matsuda,&nbsp;T Hinohara,&nbsp;Y Oh,&nbsp;K Hattori,&nbsp;K Ishikawa,&nbsp;T Ohshima,&nbsp;H Yamamoto,&nbsp;S Kato","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Five patients with Fanconi anemia have been treated by bone marrow transplantation.</p><p><strong>Patients and methods: </strong>They were conditioned with cyclophosphamide (CY) (20-150 mg/kg), antilymphocyte globulin, and thoracoabdominal irradiation (4-6 Gy). The dose of CY for preconditioning was adjusted individually, based on the in vitro effect of CY metabolites on the chromosomes of patients with Fanconi anemia. Four patients received marrow from human leukocyte antigen (HLA)-identical siblings, and one received marrow from his HLA phenotypically identical father.</p><p><strong>Results: </strong>All patients achieved engraftment, and acute graft-versus-host disease (GVHD) grade II or more was not observed. Three developed chronic GVHD. All patients are surviving 2-5 years after grafting, with hematological improvement.</p><p><strong>Conclusions: </strong>These results indicate that the individual dose adjustment of CY used for preconditioning may prevent graft failure and severe acute GVHD.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"15 4","pages":"377-82"},"PeriodicalIF":0.0000,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of pediatric hematology/oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Five patients with Fanconi anemia have been treated by bone marrow transplantation.

Patients and methods: They were conditioned with cyclophosphamide (CY) (20-150 mg/kg), antilymphocyte globulin, and thoracoabdominal irradiation (4-6 Gy). The dose of CY for preconditioning was adjusted individually, based on the in vitro effect of CY metabolites on the chromosomes of patients with Fanconi anemia. Four patients received marrow from human leukocyte antigen (HLA)-identical siblings, and one received marrow from his HLA phenotypically identical father.

Results: All patients achieved engraftment, and acute graft-versus-host disease (GVHD) grade II or more was not observed. Three developed chronic GVHD. All patients are surviving 2-5 years after grafting, with hematological improvement.

Conclusions: These results indicate that the individual dose adjustment of CY used for preconditioning may prevent graft failure and severe acute GVHD.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
骨髓移植治疗范可尼贫血。环磷酰胺预处理剂量的调整。
目的:对5例范可尼贫血患者进行骨髓移植治疗。患者和方法:采用环磷酰胺(CY) (20 ~ 150 mg/kg)、抗淋巴细胞球蛋白、胸腹照射(4 ~ 6 Gy)。根据体外CY代谢物对范可尼贫血患者染色体的影响,单独调整CY预处理剂量。四名患者接受了来自人类白细胞抗原(HLA)相同的兄弟姐妹的骨髓,一名患者接受了来自其HLA表型相同的父亲的骨髓。结果:所有患者移植成功,未观察到急性移植物抗宿主病(GVHD) II级或以上。3例发展为慢性GVHD。所有患者移植后存活2-5年,血液学改善。结论:个体化调整CY预适应剂量可预防移植物衰竭和严重急性GVHD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen. Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma. Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins. Transient abnormal myelopoiesis in Down's syndrome neonates.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1